Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Other 1

Conditions

Overweight 1Obesity 1Infertility 1Endometrial Neoplasms 1

Interventions

Tirzepatide 3naldemedine 1mirabegron 1ma zi ren wan 1exemestane 1Transcutaneous Electric Nerve Stimulation 1Tablets 1Specimen Handling 1Resistance Training 1Metformin 1Megestrol Acetate 1Leuprolide 1Letrozole 1Hypnosis 1Hydroquinones 1Goserelin 1Gonadotropin-Releasing Hormone 1Educational Status 1Cryotherapy 1Counseling 1Caloric Restriction 1Bupropion 1Ascorbic Acid 1Aromatase Inhibitors 1Anastrozole 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Megestrol Acetate × Other × 30 days × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡